Fei Yao

411 total citations
20 papers, 360 citations indexed

About

Fei Yao is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Fei Yao has authored 20 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Fei Yao's work include Plant chemical constituents analysis (3 papers), Berberine and alkaloids research (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Fei Yao is often cited by papers focused on Plant chemical constituents analysis (3 papers), Berberine and alkaloids research (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Fei Yao collaborates with scholars based in China and United States. Fei Yao's co-authors include Guorong Jiang, Lurong Zhang, Guoqiang Liang, Yan Wu, Haiyan Liu, Yunsen Li, Yan He, Bo Hu, Zhong‐Qin Liang and Yifan Zhao and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Chromatography A.

In The Last Decade

Fei Yao

19 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Yao China 12 170 60 55 52 50 20 360
Zhiyuan Lou China 12 224 1.3× 59 1.0× 47 0.9× 74 1.4× 55 1.1× 28 467
Rita Tohmé United States 9 290 1.7× 60 1.0× 50 0.9× 53 1.0× 49 1.0× 12 489
Yuting Yang China 9 182 1.1× 65 1.1× 29 0.5× 35 0.7× 65 1.3× 17 446
Hong-Zin Lee Taiwan 12 185 1.1× 44 0.7× 51 0.9× 81 1.6× 50 1.0× 14 381
Weitian Wei China 8 170 1.0× 44 0.7× 36 0.7× 105 2.0× 54 1.1× 11 389
Vikas Garg India 10 151 0.9× 73 1.2× 24 0.4× 46 0.9× 35 0.7× 36 419
Binqiang Tian China 11 268 1.6× 70 1.2× 73 1.3× 51 1.0× 91 1.8× 14 497
Haiding Huang China 12 178 1.0× 53 0.9× 57 1.0× 46 0.9× 60 1.2× 16 426
Sang‐Mi Woo South Korea 10 208 1.2× 81 1.4× 59 1.1× 38 0.7× 58 1.2× 12 379
Ke‐Ping Shen China 12 208 1.2× 68 1.1× 55 1.0× 85 1.6× 42 0.8× 21 417

Countries citing papers authored by Fei Yao

Since Specialization
Citations

This map shows the geographic impact of Fei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yao more than expected).

Fields of papers citing papers by Fei Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yao. The network helps show where Fei Yao may publish in the future.

Co-authorship network of co-authors of Fei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yao. A scholar is included among the top collaborators of Fei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yao. Fei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Linshan, Peng Yu, Fei Yao, et al.. (2024). Insulin autoantibodies, D-dimer and microalbuminuria: A cross-sectional, case-control study of type 2 diabetes. World Journal of Diabetes. 16(2). 101501–101501.
2.
Yao, Fei, Guoqiang Liang, Liang Zhou, et al.. (2024). Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway. Scientific Reports. 14(1). 31522–31522. 1 indexed citations
3.
Yao, Fei, et al.. (2023). Osteoblast Biospecific Extraction Conjugated with HPLC Analysis forScreening Bone Regeneration Active Components from Moutan Cortex. Combinatorial Chemistry & High Throughput Screening. 27(6). 834–844. 1 indexed citations
4.
Yao, Fei, et al.. (2023). A novel capacitor voltage fluctuation suppression method for the low-frequency operating stage of MMC driven pumped storage system. Journal of Energy Storage. 73. 108947–108947. 4 indexed citations
5.
Yao, Fei, et al.. (2021). Nomogram to predict haemorrhagic transformation after stroke thrombolysis: a combined brain imaging and clinical study. Clinical Radiology. 77(1). e92–e98. 7 indexed citations
6.
Yao, Fei, Guorong Jiang, Guoqiang Liang, et al.. (2021). The antitumor effect of the combination of aconitine and crude monkshood polysaccharide on hepatocellular carcinoma.. Pakistan Journal of Pharmaceutical Sciences. 34(3). 971–979. 8 indexed citations
7.
Yao, Fei, et al.. (2020). Yupingfeng Granule Improves Th2‐Biased Immune State in Microenvironment of Hepatocellular Carcinoma through TSLP‐DC‐OX40L Pathway. Evidence-based Complementary and Alternative Medicine. 2020(1). 1263053–1263053. 17 indexed citations
8.
Yao, Fei, Daiming Jiang, Weihua Guo, et al.. (2020). FABP4 inhibitor attenuates inflammation and endoplasmic reticulum stress of islet in leptin receptor knockout rats.. PubMed. 24(24). 12808–12820. 20 indexed citations
9.
Zhong, Liping, Lu Gan, Zhiming Deng, et al.. (2020). Antitumor Activity of Lipid-DNA Aptamer Modified T Lymphocytes in Carcinoma. Journal of Biomedical Nanotechnology. 16(7). 1110–1118. 8 indexed citations
10.
Zhao, Yifan, Xiao Shen, Ying Zhu, et al.. (2019). Cathepsin L-mediated resistance of paclitaxel and cisplatin is mediated by distinct regulatory mechanisms. Journal of Experimental & Clinical Cancer Research. 38(1). 333–333. 17 indexed citations
11.
Yao, Fei, Liang Zhou, Guoqiang Liang, et al.. (2019). Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma. Evidence-based Complementary and Alternative Medicine. 2019. 1–16. 14 indexed citations
12.
Wan, Yunyan, et al.. (2018). Berberine induces mitochondrial‑mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI‑H2452 cells. Oncology Reports. 40(6). 3603–3610. 26 indexed citations
13.
14.
Wang, Long, Yifan Zhao, Yajie Xiong, et al.. (2017). K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway. Experimental Cell Research. 362(2). 424–435. 21 indexed citations
15.
Xiong, Yajie, Wenjun Ji, Fei Yao, et al.. (2016). Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells. Cellular Signalling. 29. 181–191. 22 indexed citations
16.
Yan, Jidong, Jing Xu, Fei Yao, et al.. (2016). TrxR2 deficiencies promote chondrogenic differentiation and induce apoptosis of chondrocytes through mitochondrial reactive oxygen species. Experimental Cell Research. 344(1). 67–75. 20 indexed citations
17.
Zhang, Lurong, Guorong Jiang, Fei Yao, et al.. (2015). Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma. Immunopharmacology and Immunotoxicology. 37(3). 301–307. 26 indexed citations
18.
Wan, Yunyan, et al.. (2014). Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma. Tumor Biology. 35(7). 6839–6845. 23 indexed citations
19.
Zhang, Lurong, Guorong Jiang, Fei Yao, et al.. (2012). Growth Inhibition and Apoptosis Induced by Osthole, A Natural Coumarin, in Hepatocellular Carcinoma. PLoS ONE. 7(5). e37865–e37865. 109 indexed citations
20.
Watson, Eric & Fei Yao. (1992). Fast protein monitoring in fermentation broth using non-porous micropellicular reversed-phase columns. Journal of Chromatography A. 594(1-2). 392–394. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiyuan Lou Breakdown of academic impact, for papers by Rita Tohmé Breakdown of academic impact, for papers by Yuting Yang Breakdown of academic impact, for papers by Hong-Zin Lee Breakdown of academic impact, for papers by Weitian Wei Breakdown of academic impact, for papers by Vikas Garg Breakdown of academic impact, for papers by Binqiang Tian Breakdown of academic impact, for papers by Haiding Huang Breakdown of academic impact, for papers by Sang‐Mi Woo Breakdown of academic impact, for papers by Ke‐Ping Shen
Rankless by CCL
2026